| Dr Andrew J Stingo, MD | |
|
10 E Cambridge Circle Dr Ste 150, Kansas City, KS 66103-1393 | |
| (913) 233-0454 | |
| (913) 233-0649 |
| Full Name | Dr Andrew J Stingo |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 37 Years |
| Location | 10 E Cambridge Circle Dr Ste 150, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366501363 | NPI | - | NPPES |
| 206647703 | Medicaid | MO | |
| 100144210A | Medicaid | KS | |
| 100144210B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 0424529 (Kansas) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | MD103812 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Interventional Nephrology Of Kansas City Llc | 6103218755 | 2 |
News Archive
Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often lethal cancer is resistant to conventional chemotherapy.
Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers from The University of Texas M. D. Anderson Cancer Center report in the Nov. 25 issue of Molecular Cell.
GP Strategies Corporation, announced that its principal operating subsidiary, global performance improvement solutions provider General Physics Corporation, has acquired Option Six, Inc., a provider of custom courseware development with expertise in the software and pharmaceutical industries.
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
› Verified 7 days ago
| Entity Name | Nephrology Associates Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578696506 PECOS PAC ID: 9931012820 Enrollment ID: O20050721001062 |
News Archive
Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often lethal cancer is resistant to conventional chemotherapy.
Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers from The University of Texas M. D. Anderson Cancer Center report in the Nov. 25 issue of Molecular Cell.
GP Strategies Corporation, announced that its principal operating subsidiary, global performance improvement solutions provider General Physics Corporation, has acquired Option Six, Inc., a provider of custom courseware development with expertise in the software and pharmaceutical industries.
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
› Verified 7 days ago
| Entity Name | Interventional Nephrology Of Kansas City Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134882681 PECOS PAC ID: 6103218755 Enrollment ID: O20220112000416 |
News Archive
Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often lethal cancer is resistant to conventional chemotherapy.
Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers from The University of Texas M. D. Anderson Cancer Center report in the Nov. 25 issue of Molecular Cell.
GP Strategies Corporation, announced that its principal operating subsidiary, global performance improvement solutions provider General Physics Corporation, has acquired Option Six, Inc., a provider of custom courseware development with expertise in the software and pharmaceutical industries.
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew J Stingo, MD 2790 Clay Edwards Dr, Suite 410, N Kansas City, MO 64116-3276 Ph: (816) 474-9353 | Dr Andrew J Stingo, MD 10 E Cambridge Circle Dr Ste 150, Kansas City, KS 66103-1393 Ph: (913) 233-0454 |
News Archive
Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often lethal cancer is resistant to conventional chemotherapy.
Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers from The University of Texas M. D. Anderson Cancer Center report in the Nov. 25 issue of Molecular Cell.
GP Strategies Corporation, announced that its principal operating subsidiary, global performance improvement solutions provider General Physics Corporation, has acquired Option Six, Inc., a provider of custom courseware development with expertise in the software and pharmaceutical industries.
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
› Verified 7 days ago
Micholee Beth Polsak, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Kansas University Physicians Inc, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 | |
Ira William Marsh, MD Nephrology Medicare: May Accept Medicare Assignments Practice Location: 8929 Parallel Pkwy, Kansas City, KS 66112 Phone: 913-596-4000 | |
Dr. Tara L Lin, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6030 Fax: 913-588-4085 | |
Kristin N Fee, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 2027, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 | |
Donald J. Mcsweyn, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8919 Parallel Pkwy, Suite 580, Kansas City, KS 66112 Phone: 913-596-7224 Fax: 913-596-7257 | |
Dr. Dhanunjaya Lakkireddy, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Suite#g600, Kansas City, KS 66160 Phone: 913-588-9600 Fax: 913-588-9770 | |
Archana Pareek, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Division Of General And Geriatric Medicine, University, Kansas City, KS 66160 Phone: 913-588-6005 Fax: 913-588-3877 |